Dupilumab Improves Dermatology-Specific Quality of Life in Patients with Chronic Spontaneous Urticaria Inadequately Controlled with H1 Antihistamines

被引：0
|
作者：
Maurer, Marcus [1 ]
Casale, Thomas B. [2 ]
Beck, Lisa A. [3 ]
Saini, Sarbjit [4 ]
Ben-Shoshan, Moshe [5 ]
Yosipovitch, Gil [6 ]
Msihid, Jerome [7 ]
Sugerman, Philip [8 ]
Cyr, Sonya [9 ]
Thomas, Ryan [9 ]
Chuang, Chien-Chia [8 ]
机构：
[1] Charite Univ Med Berlin, Free Univ, Humboldt Univ, Fraunhofer ITMP, Berlin, Germany
[2] Univ S Florida, Tampa, FL USA
[3] Univ Rochester, Med Ctr, Rochester, NY USA
[4] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD USA
[5] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[6] Univ Miami, Miller Sch Med, Miami Itch Ctr, Miami, FL USA
[7] Sanofi, Gentilly, France
[8] Sanofi, Cambridge, MA USA
[9] Regeneron Pharmaceut Inc, Tarrytown, NY USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2024年 / 153卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
007
引用
收藏
页码：AB3 / AB3
页数：1
相关论文
共 50 条
  • [1] Dupilumab Improves Urticaria-Specific Quality of Life in Patients with Chronic Spontaneous Urticaria Uncontrolled by H1 Antihistamines
    Maurer, Marcus
    Casale, Thomas
    Yosipovitch, Gil
    Saini, Sarbjit
    Ben-Shoshan, Moshe
    Beck, Lisa
    Msihid, Jerome
    Sugerman, Philip
    Cyr, Sonya
    Thomas, Ryan
    Chuang, Chien-Chia
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB2 - AB2
  • [2] Dupilumab Improves Urticaria Activity And Quality Of Life In Patients With Chronic Spontaneous Urticaria (CSU)
    Maurer, Marcus
    Casale, Thomas
    Saini, Sarbjot
    Ben-Shoshan, Moshe
    Radin, Allen
    Akinlade, Bolanle
    Fan, Chunpeng
    Bauer, Deborah
    Laws, Elizabeth
    Thomas, Ryan
    Mannent, Leda
    Stjepanovic, Aleksandra
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB98 - AB98
  • [3] Dupilumab Improves Urticaria Signs and Symptoms and Quality of Life in Patients With Chronic Spontaneous Urticaria (CSU)
    Maurer, Marcus
    Casale, Thomas B.
    Saini, Sarbjit S.
    Ben-Shoshan, Moshe
    Radin, Allen
    Bauer, Deborah
    Thomas, Ryan B.
    Mannent, Leda P.
    Stjepanovic, Aleksandra
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB40 - AB40
  • [4] Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria
    Finlay, A. Y.
    Kaplan, A. P.
    Beck, L. A.
    Antonova, E. N.
    Balp, M-M
    Zazzali, J.
    Khalil, S.
    Maurer, M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (10) : 1715 - 1721
  • [5] H1-antihistamines for chronic spontaneous urticaria
    Sharma, Maulina
    Bennett, Cathy
    Cohen, Stuart N.
    Carter, Ben
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (11):
  • [6] Ligelizumab Improves Dermatology Quality Of Life In Patients With Chronic Spontaneous Urticaria Regardless of Angioedema Status At Baseline
    Soong, Weily
    Bernstein, Jonathan
    Sitz, Karl
    Maurer, Marcus
    Gimenez-Arnau, Ana
    Ortmann, Christine-Elke
    Severin, Thomas
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB180 - AB180
  • [7] Review of H1 antihistamines in the treatment of chronic idiopathic urticaria
    Monroe, E
    [J]. CUTIS, 2005, 76 (02): : 118 - 126
  • [8] Remibrutinib Treatment Improves Quality of Life in Patients with Chronic Spontaneous Urticaria
    Maurer, Marcus
    Gimenez-Arnau, Ana
    Jain, Vipul
    Tillinghast, Jeffrey
    Tolcachier, Alberto
    Nigen, Simon
    Hayam, Koremasa
    Lheritier, Karine
    Walsh, Pauline
    Haemmerle, Sibylle
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB179 - AB179
  • [9] EFFICACY OF LIGELIZUMAB IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA INADEQUATELY CONTROLLED WITH OMALIZUMAB
    Sussman, G.
    Sitz, K.
    Metz, M.
    Hide, M.
    Maurer, M.
    Barbier, N.
    Hua, E.
    Janocha, R.
    Severin, T.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) : S13 - S14
  • [10] Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study
    Saini, Sarbjit S.
    Bindslev-Jensen, Carsten
    Maurer, Marcus
    Grob, Jean-Jacques
    Baskan, Emel Bulbul
    Bradley, Mary S.
    Canvin, Janice
    Rahmaoui, Abdelkader
    Georgiou, Panayiotis
    Alpan, Oral
    Spector, Sheldon
    Rosen, Karin
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 (01) : 67 - 75
12345